Beijing Tiantan Biological Products Co., Ltd. (600161.SS)
CNY 20.69
(-1.0%)
CNY 20.69
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.18 Billion | 4.26 Billion | 4.11 Billion | 3.44 Billion | 3.28 Billion | 2.93 Billion |
| Cost of Revenue | 2.61 Billion | 2.17 Billion | 2.15 Billion | 1.73 Billion | 1.64 Billion | 1.54 Billion |
| Gross Profit | 2.56 Billion | 2.09 Billion | 1.95 Billion | 1.71 Billion | 1.63 Billion | 1.38 Billion |
| Operating Expenses | 824.72 Million | 758.36 Million | 769.83 Million | 638.03 Million | 607.63 Million | 526.63 Million |
| Selling, General and Administrative Expenses | 686.48 Million | 351.87 Million | 348.24 Million | 308.96 Million | 292.75 Million | 249.5 Million |
| Research and Development Expenses | 132.98 Million | 122.01 Million | 133.2 Million | 119.87 Million | 118.67 Million | 105.36 Million |
| Other Expenses | -1.9 Million | 284.47 Million | 288.38 Million | 209.19 Million | 196.2 Million | -429.67 Thousand |
| Cost and Expenses | 3.37 Billion | 2.92 Billion | 2.92 Billion | 2.37 Billion | 2.25 Billion | 2.07 Billion |
| Operating Income | 1.8 Billion | 1.43 Billion | 1.24 Billion | 1.1 Billion | 1.04 Billion | 868.35 Million |
| Interest Expense | 6 Million | 2.41 Million | 3.08 Million | 2.98 Million | 896.6 Thousand | 6.01 Million |
| Income Tax Expense | 289.13 Million | 221.43 Million | 172.2 Million | 161.79 Million | 149.19 Million | 132.03 Million |
| Earnings before Tax | 1.79 Billion | 1.42 Billion | 1.24 Billion | 1.1 Billion | 1.04 Billion | 867.92 Million |
| Net Income | 1.1 Billion | 1.2 Billion | 1.06 Billion | 943.07 Million | 894.25 Million | 509.47 Million |
| Earnings Per Share Basic | 0.56 | 0.73 | 0.67 | 0.63 | 0.59 | 0.34 |
| Earnings Per Share Diluted | 0.56 | 0.73 | 0.67 | 0.63 | 0.59 | 0.34 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.64 Billion | 1.6 Billion | 1.5 Billion | 1.5 Billion | 1.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.64 Billion | 1.6 Billion | 1.5 Billion | 1.5 Billion | 1.49 Billion |
| Gross Margin | 0.50 | 0.49 | 0.48 | 0.50 | 0.50 | 0.47 |
| EBIT Margin | 0.40 | 0.37 | 0.34 | 0.36 | 0.36 | 0.34 |
| Profit Margin | 0.21 | 0.28 | 0.26 | 0.27 | 0.27 | 0.17 |
| EBITDA | 2.07 Billion | 1.62 Billion | 1.4 Billion | 1.25 Billion | 1.17 Billion | 1 Billion |
| Earnings Before Tax Margin | 0.35 | 0.34 | 0.30 | 0.32 | 0.32 | 0.30 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.23 Billion | 1.61 Billion | 1.2 Billion | 1.14 Billion | 5.13 Billion | 1.33 Billion |
| Cost of Revenue | 560.07 Million | 722.82 Million | 536.72 Million | 540 Million | 2.61 Billion | 641.82 Million |
| Gross Profit | 671.91 Million | 896.59 Million | 672.93 Million | 608.83 Million | 2.51 Billion | 689.21 Million |
| Operating Expenses | 153.25 Million | 944.12 Million | 188.36 Million | 279.83 Million | 821.37 Million | 203 Million |
| Selling, General and Administrative Expenses | 246.88 Million | 126.99 Million | 163.67 Million | 198.75 Million | - | 319.98 Million |
| Research and Development Expenses | 29.73 Million | 44.51 Million | 24.45 Million | 79.29 Million | - | 32.45 Million |
| Other Expenses | -123.36 Million | -944.12 Million | -243.2 Thousand | -1.79 Million | -1.9 Million | -1.63 Million |
| Cost and Expenses | 713.32 Million | 944.12 Million | 725.09 Million | 819.84 Million | 3.43 Billion | 844.83 Million |
| Operating Income | 535.03 Million | 675.28 Million | 484.56 Million | 328.99 Million | 1.69 Billion | 507.63 Million |
| Interest Expense | 1.25 Million | 1.35 Million | 1.19 Million | -391.62 Thousand | 3.65 Million | 1.38 Million |
| Income Tax Expense | 92.13 Million | 380.05 Million | 84.09 Million | 55.7 Million | 289.13 Million | 72.57 Million |
| Earnings before Tax | 534.06 Million | 674.13 Million | 516.22 Million | 357.54 Million | 1.79 Billion | 505.99 Million |
| Net Income | 325.63 Million | 294.08 Million | 316.67 Million | 222.48 Million | 1.1 Billion | 320.6 Million |
| Earnings Per Share Basic | 0.16 | 0.18 | 0.19 | 0.14 | - | 0.19 |
| Earnings Per Share Diluted | 0.16 | 0.18 | 0.19 | 0.14 | - | 0.19 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion |
| Gross Margin | 0.55 | 0.55 | 0.56 | 0.53 | 0.49 | 0.52 |
| EBIT Margin | 0.43 | 0.18 | 0.43 | 0.35 | - | 0.38 |
| Profit Margin | 0.26 | 0.18 | 0.26 | 0.19 | 0.22 | 0.24 |
| EBITDA | 535.32 Million | 295.23 Million | 517.57 Million | 406.01 Million | - | 508.46 Million |
| Earnings Before Tax Margin | 0.43 | 0.42 | 0.40 | 0.29 | 0.33 | 0.38 |
STMRF
FBLG
605388
SCANFL
TM
BOWFF